BRAF and neuroepithelial neoplasm: BRAF gene mutation has been found in 43.8% solitary DIA/DIGs recently (27, 28), which hinted DIA/DIGs were another low-grade MAPK pathway-driven neuroepithelial tumor and might allow for the use of targeted molecular therapies, such as vemurafenib (29).